Are Options A Good Investment Right Now? Nektar Therapeutics (NKTR) Stock
Rodman & Renshaw raised the price target for the Nektar Therapeutics (NASDAQ:NKTR) stock to “a Buy”. The rating was released on June 28, 2024, according to finviz. The stock was upgraded by Jefferies, who disclosed in a research note on May 10, 2023, from Underperform to Hold and set the price objective to $1. In […]
Is it possible to sustain this rally? Nektar Therapeutics (NKTR) Stock
Rodman & Renshaw raised the price target for the Nektar Therapeutics (NASDAQ:NKTR) stock to “a Buy”. The rating was released on June 28, 2024, according to finviz. The stock was upgraded by Jefferies, who disclosed in a research note on May 10, 2023, from Underperform to Hold and set the price objective to $1. In […]
Does Nektar Therapeutics (NKTR) Stock Really Excited You?
Rodman & Renshaw raised the price target for the Nektar Therapeutics (NASDAQ:NKTR) stock to “a Buy”. The rating was released on June 28, 2024, according to finviz. The stock was upgraded by Jefferies, who disclosed in a research note on May 10, 2023, from Underperform to Hold and set the price objective to $1. In […]
What is happening with Nektar Therapeutics (NKTR) Stock?
Rodman & Renshaw raised the price target for the Nektar Therapeutics (NASDAQ:NKTR) stock to “a Buy”. The rating was released on June 28, 2024, according to finviz. The stock was upgraded by Jefferies, who disclosed in a research note on May 10, 2023, from Underperform to Hold and set the price objective to $1. In […]
A leader in the success game: Nektar Therapeutics (NKTR) Stock
Rodman & Renshaw raised the price target for the Nektar Therapeutics (NASDAQ:NKTR) stock to “a Buy”. The rating was released on June 28, 2024, according to finviz. The stock was upgraded by Jefferies, who disclosed in a research note on May 10, 2023, from Underperform to Hold and set the price objective to $1. In […]
Growing at an Unbelievable Rate: Nektar Therapeutics (NKTR) Stock
Rodman & Renshaw raised the price target for the Nektar Therapeutics (NASDAQ:NKTR) stock to “a Buy”. The rating was released on June 28, 2024, according to finviz. The stock was upgraded by Jefferies, who disclosed in a research note on May 10, 2023, from Underperform to Hold and set the price objective to $1. In […]
Why Nektar Therapeutics (NASDAQ:NKTR) Stock climbed 34.94% in Last Three Months?
Rodman & Renshaw raised the price target for the Nektar Therapeutics (NASDAQ:NKTR) stock to “a Buy”. The rating was released on June 28, 2024, according to finviz. The stock was upgraded by Jefferies, who disclosed in a research note on May 10, 2023, from Underperform to Hold and set the price objective to $1. In […]
Rodman & Renshaw raised the price target for the Nektar Therapeutics (NASDAQ:NKTR) stock to “”a Buy””
Rodman & Renshaw raised the price target for the Nektar Therapeutics (NASDAQ:NKTR) stock to “a Buy”. The rating was released on Jun-29-24, according to finviz. The stock was upgraded by Jefferies, who disclosed in a research note on May 10, 2023, from Underperform to Hold and set the price objective to $1. In their research […]
Nektar Therapeutics (NKTR) Stock Has More Upside Than Fundamentals Suggest
JP Morgan raised the price target for the Nektar Therapeutics (NASDAQ:NKTR) stock to “an Underweight”. The rating was released on November 20, 2023, according to finviz. The research report from Jefferies has upgraded the stock from Underperform to Hold, with a price target set at $1. The stock was downgraded by Jefferies, who disclosed in […]
Nektar Therapeutics (NKTR) Stock is Just Right Size-Neither Too Big Nor Too Small
JP Morgan raised the price target for the Nektar Therapeutics (NASDAQ:NKTR) stock to “an Underweight”. The rating was released on November 20, 2023, according to finviz. The research report from Jefferies has upgraded the stock from Underperform to Hold, with a price target set at $1. The stock was downgraded by Jefferies, who disclosed in […]
